EP Patent

EP4262983A1 — Solid forms of baloxavir, salts of baloxavir and cocrystals of baloxavir

Assigned to Synthon BV · Expires 2023-10-25 · 3y expired

What this patent protects

The presented invention relates to Baloxavir, salts of Baloxavir, cocrystals of Baloxavir, to solid forms of thereof and to processes for preparation thereof.

USPTO Abstract

The presented invention relates to Baloxavir, salts of Baloxavir, cocrystals of Baloxavir, to solid forms of thereof and to processes for preparation thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP4262983A1
Jurisdiction
EP
Classification
—
Expires
2023-10-25
Drug substance claim
No
Drug product claim
No
Assignee
Synthon BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.